Refeyn
PrivateLast Round
Series B
Apr 11, 2022
Total Funding Raised
$99.93M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Refeyn is a life sciences instrumentation company that develops, produces, and distributes mass photometry technology for the analysis of individual molecules in solution.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Refeyn Comparables
Compare Refeyn with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoTemper Technologies | 78% | |
| Unchained Labs | 76% | |
| Nicoya Lifesciences Inc. | 74% | |
Refeyn Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 11, 2022 | ||||
| Series A | Nov 1, 2020 | ||||
| Seed | Mar 4, 2019 | ||||
| Seed | Jun 26, 2018 |
Refeyn Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foresight Group Holdings Limited | Series B |
| Horizons Ventures | Series A, Series B |
| Oxford Science Enterprises | Series A, Series B, Seed |
| Northpond Ventures | Series A, Series B |
| University of Oxford | Seed, Series A, Series B |
| Foresight Group LLP | Series A, Series B |
| Foresight Williams Technology | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
Launched the MyMass instrument for sample quality assessment.
- Nov 5, 2025
Company has grown to over 170 employees.
Refeyn Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Refeyn's valuation, stock price, and market status.